IP Library › Patent Application 10549902
Patent Application
App. No. 10/549,902

Anti-inflammatory treatment

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/549,902
Abstract

The invention provides a method of treatment of a human or non-human animal subject to combat inflammation arising from a condition associated with pain or a condition not associated with pain, said method comprising administering to said subject an effective amount of a physiologically tolerable strontium compound.

Claims (17)

1 . A method of treatment of a human or non-human animal subject to combat inflammation arising from a condition associated with pain or a condition not associated with pain, said method comprising administering to said subject an effective amount of a physiologically tolerable strontium compound.

2 . The method as claimed in claim 1 , wherein said strontium compound is administered to the surface of the skin.

3 . The method as claimed in claim 1 , wherein said inflammation is not associated with pain.

4 . The method as claimed in claim 1 , wherein said inflammation is not associated with a sporting injury.

5 . The method as claimed in claim 1 , wherein said administration is not oral.

6 - 7 . (canceled)

8 . The method as claimed in claim 1 , wherein said strontium compound is administered further with a skin penetration enhancing agent.

9 . The method as claimed in claim 8 , wherein said skin penetration enhancing agent is dimethylsulphoxide.

10 . The method as claimed in claim 1 , wherein said strontium compound is selected from the group consisting of strontium chloride, strontium acetate and strontium nitrate.

11 . The method as claimed in claim 1 , wherein said strontium compound is a strontium complex with a chelating agent.

12 . The method as claimed in claim 11 , wherein said chelating agent is present in at least 2% mol excess relative to strontium.

13 . The method as claimed in claim 12 , wherein said chelating agent is present in an excess of at least 50% mol relative to strontium.

14 . The method as claimed in claim 1 , wherein said inflammation is associated with acne vulgaris.

15 . The method as claimed in claim 1 , wherein said inflammation is associated with psoriasis.

16 . The method as claimed in claim 1 , wherein said inflammation is associated with radiation therapy.

17 . The method as claimed in claim 1 , wherein said inflammation is associated with arthritis.

18 . The method as claimed in claim 2 , wherein said inflammation is not associated with pain.

Assignments (2)
CHANGE OF NAME Recorded Sep 18, 2015
From: SANTOSOLVE AS
To: SANA PHARMA MEDICAL AS
Reel/Frame 036640/0102 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2006
From: JELLUM, EGIL; FAGERLUND, BJORN JARL; KJOLBERG, CLAS MAGNE; KLAVENESS, JO; EGE, THORFINN
To: SANTOSOLVE AS
Reel/Frame 018600/0622 →